Compare MLEC & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLEC | VVOS |
|---|---|---|
| Founded | 2008 | 2016 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0M | 4.8M |
| IPO Year | 2022 | 2020 |
| Metric | MLEC | VVOS |
|---|---|---|
| Price | $6.10 | $0.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | 17.5K | ★ 14.5M |
| Earning Date | 05-12-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.76 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $17,443,000.00 |
| Revenue This Year | $20.42 | $69.66 |
| Revenue Next Year | $30.00 | $48.38 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.05 |
| 52 Week Low | $0.21 | $0.16 |
| 52 Week High | $23.22 | $3.61 |
| Indicator | MLEC | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 39.63 | 31.88 |
| Support Level | $5.41 | $0.16 |
| Resistance Level | $9.23 | $0.55 |
| Average True Range (ATR) | 0.64 | 0.04 |
| MACD | -0.09 | 0.00 |
| Stochastic Oscillator | 4.46 | 2.27 |
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.